Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway

J Musculoskelet Neuronal Interact. 2022 Jun 1;22(2):242-250.

Abstract

Objectives: a) To explore the expression of Foxf1 and NF-κB in bone tissue of ovariectomized rats with osteoporosis and b) to investigate the role and mechanism of NF-κB pathway regulated by Foxf1 gene in the differentiation and formation of rat osteoclasts and osteoblasts with cell experiments.

Methods: Ovariectomized rat model of osteoporosis was established with 3-month-old female SD rats. The rats were divided into sham group (n=10) and osteoporosis group (n=10). Real time fluorescent quantitative PCR and Western blot were used to detect the expression levels of Foxf1 and NF-κB genes and proteins in the femur tissues of rats and analyze their correlation.

Results: Both Foxf1 and NF- κB were highly expressed in the femur tissues. Upon the overexpression of Foxf1 gene in osteoblasts and osteoclasts in vitro, the gene and protein expression of NF-κB were also upregulated, significantly reducing the gene and protein expression levels of osteogenic factors, including ATF4, OCN, ALP and Runx2.

Conclusions: Foxf1 gene could inhibit osteoblast formation and promote osteoclast differentiation by NF-κB pathway, which may increase the risk of osteoporosis in rats.

Keywords: Foxf1 Gene; NF-κB Pathway; Osteoblasts; Osteoclasts; Osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Forkhead Transcription Factors* / genetics
  • NF-kappa B* / genetics
  • Osteoblasts / cytology
  • Osteoclasts / cytology
  • Osteoporosis* / genetics
  • Osteoporosis* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Up-Regulation

Substances

  • Forkhead Transcription Factors
  • NF-kappa B